Achondroplasia Clinical Trials

Find Achondroplasia Clinical Trials Near You

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia Using Syde®

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history study to measure limb movements in patients with ACH or HCH.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 65
Healthy Volunteers: f
View:

• Aged 3 years old or older at the time of consent.

• Written informed consent obtained:

‣ From the parent(s) or legal guardian(s) for participants under 18 years old.

⁃ From participants 18 years old and older.

• Affiliated to, or beneficiary of a social security category

• Able to walk unassisted for at least 10 meters.

• Genetically confirmed diagnosis with one pathogenic variant (ACMG class IV \& V) of achondroplasia or hypochondroplasia.

• Participant (and caregivers for participants under 18 years old) willing and able to comply with all study procedures including: questionnaires, Syde® related procedures

Locations
Other Locations
France
Hopital Necker
RECRUITING
Paris
Contact Information
Primary
Ferial Toumi
ferial.toumi@sysnav.fr
+33 2 78 00 10 98
Time Frame
Start Date: 2026-02-06
Estimated Completion Date: 2028-02
Participants
Target number of participants: 40
Related Therapeutic Areas
Sponsors
Leads: SYSNAV

This content was sourced from clinicaltrials.gov